THX Pharma unveils its 2026 financial calendar

On January 20, 2026, THX Pharma, a biopharmaceutical company specializing in rare neurological diseases, published its financial calendar for 2026. Financial releases will take place after the close of trading on Euronext Paris. This schedule is, however, subject to change.

The details include key publications such as cash flow data as of December 31, 2025, scheduled for February 19. Annual results and cash flow as of March 31, 2026, will be released on April 28. The Annual General Meeting will be held on June 23 at 10:00 a.m., followed by the release of cash flow as of June 30, scheduled for July 9. Half-year results and cash flow as of September 30 will be announced on September 29 and October 22, respectively.